Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

MPDU1 Activators

Dolichol phosphate stands out as a key player, providing the essential lipid framework required for the assembly of glycan precursors. Its abundance is closely tied to the efficiency of MPDU1's function, as it is directly utilized in the production of dolichol-linked sugars that are vital for glycoprotein maturation.

Chemicals like tunicamycin and swainsonine, although typically characterized as inhibitors of specific glycosylation enzymes, can paradoxically induce compensatory cellular responses. These responses might upregulate the glycosylation machinery, potentially enhancing the pathways where MPDU1 is active. This indirect activation can be thought of as a stress response, wherein the cell attempts to counterbalance the inhibition of glycosylation, potentially increasing the functional activity of MPDU1-related pathways.

Similarly, castanospermine and deoxymannojirimycin, by inhibiting mannosidase enzymes, may lead to an accumulation of glycosylation intermediates. This build-up can, in turn, stimulate the utilization of these intermediates in the enzymatic processes that MPDU1 is associated with. The enhanced demand for the utilization of these intermediates can be perceived as an indirect activation of MPDU1's role in the glycosylation pathway. Moreover, molecules like brefeldin A and nocodazole, which disrupt the normal functioning of the Golgi apparatus, might also indirectly influence the activity of MPDU1. By altering the cellular environment, they can trigger a cascade of changes that affect various aspects of glycosylation, including those dependent on MPDU1.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Tunicamycin

11089-65-9sc-3506A
sc-3506
5 mg
10 mg
$169.00
$299.00
66
(3)

Inhibits N-linked glycosylation; by inhibiting early steps, it might upregulate other aspects of glycosylation machinery to compensate, indirectly affecting MPDU1's role.

Swainsonine

72741-87-8sc-201362
sc-201362C
sc-201362A
sc-201362D
sc-201362B
1 mg
2 mg
5 mg
10 mg
25 mg
$135.00
$246.00
$619.00
$799.00
$1796.00
6
(1)

Inhibits glycoprotein processing; could lead to upregulation of upstream glycosylation pathways, including those associated with MPDU1.

Castanospermine

79831-76-8sc-201358
sc-201358A
100 mg
500 mg
$180.00
$620.00
10
(1)

Inhibitor of glucosidase I and II; impacts glycoprotein processing and could influence MPDU1 through compensatory cellular responses.

Deoxynojirimycin

19130-96-2sc-201369
sc-201369A
1 mg
5 mg
$72.00
$142.00
(0)

Glucosidase inhibitor; can increase the pool of glycosylation intermediates, potentially enhancing MPDU1 activity.

Deoxymannojirimycin hydrochloride

84444-90-6sc-201360
sc-201360A
1 mg
5 mg
$93.00
$239.00
2
(0)

Mannosidase inhibitor; may affect upstream glycosylation processes and alter MPDU1 activity indirectly.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Disrupts Golgi structure; may affect glycosylation pathways and indirectly the function of MPDU1.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$58.00
$83.00
$140.00
$242.00
38
(2)

Microtubule disruptor; influences Golgi apparatus dynamics and could indirectly affect MPDU1 function.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$152.00
$515.00
(1)

Ionophore that alters Golgi pH; can influence glycosylation processes and indirectly MPDU1's role.

Kifunensine

109944-15-2sc-201364
sc-201364A
sc-201364B
sc-201364C
1 mg
5 mg
10 mg
100 mg
$132.00
$529.00
$1005.00
$6125.00
25
(2)

Mannosidase inhibitor; impacts the glycosylation processing pathway, potentially altering MPDU1 function.

N6-Cyclopentyladenosine

41552-82-3sc-204117
50 mg
$120.00
2
(0)

Non-hydrolyzable ATP analog; can bind and influence enzymes that are ATP-dependent, possibly affecting those involved in glycosylation and MPDU1's activity.